The patient drives our decisions

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses. 

The patient drives our decisions and our guiding principles foster a culture that seeks to create lasting social value by helping to address one of the most urgent epidemics of our time.   
One day addiction will no longer be viewed through the social lens of scorn and shame. One day addiction will no longer be a global humanitarian crisis. We at Indivior envision a day in which all patients around the world will have unrestricted access to high quality treatment services for the chronic relapsing conditions and co-morbidities of addiction. 

Until that day comes, we will continue to pioneer life-transforming treatments. And with the help of healthcare professionals, the public health community, policy makers, payers, and people like you, we will break down barriers to treatment for millions of people across the globe that need it most.
This is our vision. We are Indivior and we will always focus on you.

Continue to

Product query or adverse event

Patient safety is not just an obligation … it is a responsibility.

Your help in reporting product concerns or adverse events plays a crucial role in our mission to ensure all patients have access to high-quality treatments. We take every opportunity to monitor patient safety with appropriate tools.

For any safety related information, product complaints, to request medical information, or to report an adverse event please contact:


Cookie policy


Privacy policy


Privacy Notice Healthcare Professionals


Indivior is committed to complying with federal and applicable state laws and regulations, as well as the Corporate Integrity Agreement (CIA) which Indivior entered into with the Office of the Inspector General for the Department of Health and Human Services in July 2020.


Payments to Australia Healthcare Professionals and Organizations

To demonstrate Indivior’s commitment to transparency and in compliance with the Medicines Australia Code of Conduct, payments and other transfers of value provided to Australian health consumer organizations and healthcare professionals can be found below.

Healthcare Professional Payments

HCP payments May 2023 – October 2023

HCP payments November 2022 – April 2023

HCP payments May 2022 – October 2022 

HCP payments November 2021 - April 2022

HCP payments May 2021 – October 2021

HCP payments November 2020 – April 2021

HCP payments May 2020 - October 2020

HCP payments November 2019 – April 2020

Health Consumer Organisation Support Reports

HCO payments 2022

HCO payments 2021

HCO payments 2020

Third Party Meetings and Symposia Sponsorships

Third-Party Meetings and Symposia Sponsored May 2023 - October 2023

Third Party Meeting and Symposia Sponsorships November 2022  -  April 2023

Third Party Meeting and Symposia Sponsorships May - October 2022

Third Party Meeting and Symposia Sponsorship November 2021 - April 2022 

Third Party Meeting and Symposia Sponsorship May 2021 - October 2021

Third Party Meeting and Symposia Sponsorship November 2020 – April 2021

Third Party Meeting and Symposia Sponsorships May 2020 – October 2020

Third Party Meeting and Symposia Sponsorships November 2019 – April 2020


Questions about Indivior’s transparency program can be addressed by telephone - 1-877-886-3828 or by email at